ETF Holdings Breakdown of MLYS

Stock NameMineralys Therapeutics, Inc. Common Stock
TickerMLYS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6031701013

News associated with MLYS

Mineralys Therapeutics (NASDAQ:MLYS) Sees Strong Trading Volume on Analyst Upgrade
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) saw strong trading volume on Wednesday after HC Wainwright raised their price target on the stock from $30.00 to $42.00. HC Wainwright currently has a buy rating on the stock. 303,503 shares were traded during trading, a decline of 17% from the previous session’s volume of 367,553 […] - 2025-04-04 05:17:07
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Shares Bought by AlphaQuest LLC
AlphaQuest LLC boosted its stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) by 2,637.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 15,222 shares of the company’s stock after purchasing an additional 14,666 shares during the period. AlphaQuest LLC’s holdings in Mineralys Therapeutics were worth $187,000 at the end of the […] - 2025-03-17 08:03:05
23,192 Shares in Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Acquired by Proficio Capital Partners LLC
Proficio Capital Partners LLC purchased a new position in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 23,192 shares of the company’s stock, valued at approximately $285,000. Other institutional investors and hedge funds have also bought and […] - 2025-03-12 07:14:51
HC Wainwright Reiterates Buy Rating for Mineralys Therapeutics (NASDAQ:MLYS)
HC Wainwright restated their buy rating on shares of Mineralys Therapeutics (NASDAQ:MLYS – Free Report) in a report issued on Monday morning,Benzinga reports. The firm currently has a $30.00 price objective on the stock. MLYS has been the subject of several other research reports. Guggenheim restated a “buy” rating on shares of Mineralys Therapeutics in […] - 2025-03-11 06:40:47

MLYS institutional holdings

The following institutional investment holdings of MLYS have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 23,875USD 372,689
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 23,875USD 372,689 5.4%
Total =47,750 USD 745,378
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.